Genpact(G) Prnewswire·2024-07-30 20:30Core Insights - Genpact has been recognized as a Leader in the Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® assessment for 2024 due to its advanced digital and AI solutions [1][2][3] - The company has established strategic partnerships with firms like AWS and Veeva, enhancing its service offerings in the life sciences sector [1][2] - Genpact's innovative solutions include Health Agency Q&A, which automates responses to health authority inquiries using generative AI and Natural Language Processing, and Marketing Authorization Supply Transfer, which integrates planning and tracking of regulatory milestones [2][3] Company Overview - Genpact is a global professional services and solutions firm with over 125,000 employees across more than 30 countries, focusing on delivering outcomes that shape the future [4] - The company emphasizes its commitment to creating lasting value for clients, including those in the Fortune Global 500, through deep industry knowledge and expertise in digital operations, data, technology, and AI [4] Industry Context - Life sciences enterprises are increasingly relying on external service providers like Genpact to navigate complex compliance systems and adapt to shifting regulations [3] - The demand for advanced technology and deep expertise in regulatory affairs is growing, positioning Genpact favorably in the market [3]